CSIMarket Company Name, Ticker, Customers, else..
 
Boundless Bio Inc   (NASDAQ: BOLD)
 
Price: $2.8550 $0.05 1.601%
Day's High: $2.880000114440918 Week Perf: -2.06 %
Day's Low: $ 2.81 30 Day Perf: 11.09 %
Volume (M): 35,590 52 Wk High: $ 3.16
Volume (M$): $ 0 52 Wk Avg: $1.54
Open: $2.81 52 Wk Low: $0.96



 Market Capitalization (Millions $) 64
 Shares Outstanding (Millions) 22
 Employees 28
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -64
 Cash Flow (TTM) (Millions $) 3
 Capital Exp. (TTM) (Millions $) 0

Business Description


Audentes Therapeutics Inc is a biotechnology company that specializes in the development and commercialization of gene therapies for the treatment of rare muscle diseases. The company is primarily focused on developing treatments for neuromuscular conditions such as spinal muscular atrophy (SMA) and myotonic dystrophy. Audentes aims to provide innovative and potentially life-changing therapies for patients with limited treatment options. They utilize advanced genetic engineering techniques to deliver functioning copies of genes to targeted cells, thereby restoring normal function and improving patient outcomes. The company was founded in 2012 and is headquartered in San Francisco, California. Audentes Therapeutics Inc has gained recognition for its groundbreaking research and commitment to addressing unmet medical needs in the field of rare diseases.


   Company Address: 10955 Alexandria Way San Diego 92121 CA
   Company Phone Number: 766-9912   Stock Exchange / Ticker: NASDAQ BOLD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ATNM   -6.48%    
CUE        2.7% 
GNPX   -12%    
NERV   -7.6%    
NKTX   -2.03%    
SXTP   -6.84%    
• View Complete Report
   



Clinical Study

Boundless Bio Finds Stability Amid Industry Turbulence A Look at Recent Developments and Resilience in Financial Perf...

Published Thu, Dec 12 2024 9:01 PM UTC

In a landscape where many biotechnology firms are grappling with significant revenue declines, Boundless Bio Inc. has emerged with a surprising steadiness, maintaining its financial position while revamping its strategic approach. The company s recently announced pipeline and leadership updates highlight its determination to navigate through a complex and often tumultuous in...
Stocks on the Move

Audentes Therapeutics Inc Faces Underperformance Amidst Varied Market Conditions

Published Thu, Jul 11 2024 5:41 AM UTC

Audentes Therapeutics Inc, a biotechnology company specializing in gene therapy, has been experiencing a decline in share performance this week. Several factors have contributed to this underperformance, including concerns about the company s financials, market trends, the closure of a gene therapy manufacturing facility, and the emergence of competitor companies. This artic...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 0.97
PEG (TTM) -

Financial Strength Current
Quick Ratio 25
Working Capital Ratio 25.14
Leverage Ratio (MRQ) 0.12
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -2.86 $
Revenues (TTM) -
Cash Flow (TTM) 0.12 $
Cash 8.65 $
Book Value 2.94 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -2,286,143
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.